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Background: Several malaria vaccines are currently in clinical trials and are expected to provide an improved
strategy for malaria control. Prior to introduction of a new vaccine, policymakers must consider the socio cultural
environment of the region to ensure widespread community approval. This study investigated the acceptance of a
malaria vaccine by child caregivers and analysed factors that influence these.
Methods: Interviews from a standard questionnaire were conducted with 2,003 caregivers at 695 randomly
selected health facilities across Kenya during the Kenya Service Provision Assessment Survey 2010. Multinomial
regression of quantitative data was conducted using STATA to analyse determinants of caregivers accepting malaria
vaccination of their child.
Results: Mothers represented 90% of caregivers interviewed who brought their child to the health facility, and 77%
of caregivers were 20-34 years old. Overall, 88% of respondents indicated that they would accept a malaria vaccine,
both for a child in their community and their own child. Approval for a vaccine was highest in malaria-endemic
Nyanza Province at 98.9%, and lowest in the seasonal transmission area of North Eastern Province at 23%. Although
94% of respondents who had attended at least some school reported they would accept the vaccine for a child,
only 56% of those who had never attended school would do so. The likelihood of accepting one’s own child to be
immunized was correlated with province, satisfaction with health care services in the facility attended, age of the
caregiver, and level of education.
Conclusions: Results from this study indicate a need for targeted messages and education on a malaria vaccine,
particularly for residents of regions where acceptance is low, older caregivers, and those with low literacy and
school-attendance levels. This study provides critical evidence to inform policy for a new malaria vaccine that will
support its timely and comprehensive uptake in Kenya.
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While childhood mortality is decreasing in Africa as a
whole, malaria-specific mortality persists as a heavy pub-
lic health burden, particularly in sub-Saharan Africa.
Multiple malaria interventions, including vector control
measures, intermittent preventative treatment, and anti-
malarial drugs have long been in use to prevent or treat
malaria. Even though notable progress has been made,
more work is needed and new challenges are emerging.
Drug resistance as well as insecticide-resistant mosqui-
toes, are growing threats in many areas. This is illustrated* Correspondence: David.ojakaa@amref.org
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unless otherwise stated.by the re-emergence of the disease in areas that had previ-
ously seen reductions in the malaria burden and been
malaria-free [1,2]. This represents a major threat for mal-
aria control and elimination, illuminating the need to de-
velop new tools in order to re-enforce the package of
existing interventions.
Development of a malaria vaccine is envisaged to pro-
vide a cost-effective reduction of the disease. Current
progress toward developing a malaria vaccine has accel-
erated in the last decade with increased funding and re-
search driving the discovery of new antigens and vaccine
technology, and many more malaria vaccine candidates
being moved through the development pipeline. The future
of malaria vaccine development is promising particularlyLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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clinically advanced malaria vaccine candidate in the world.
It is a recombinant protein that fuses a part of the Plasmo-
dium falciparum circumsporozoite protein with the hepa-
titis B virus surface antigen, combined with an adjuvant.
RTS,S vaccine induces the production of antibodies and T
cells that are believed to diminish the malaria parasite’s
ability to infect, develop, and survive in the human liver.
The vaccine is undergoing phase III clinical trials in seven
African countries (Burkina Faso, Gabon, Ghana, Kenya,
Malawi, Mozambique, and Tanzania), with 15,460 infants
and young children participating. Results in African chil-
dren showed that it protects 31% of young infants and
56% of older babies and toddlers from P. falciparum, the
most life-threatening malaria parasite [3,4], but efficacy
declined to 29.9% and 16.8% against first and all episodes
of P. falciparum clinical malaria respectively, among chil-
dren vaccinated at 5 to 17 months of age during 4 years
of follow-up at one Kenyan site [5]. The multicentre RTS,
S assessment is expected to run until late 2014, and is be-
ing conducted in three regions in Kenya, in addition to
nine sites in the other African countries. Furthermore, a
recent study reported that another vaccine containing live
sporozoites of P. falciparum demonstrated potential for
high-level protection against malaria in Phase I clinical
trials [6].
If the required public health information comprising
safety and efficacy data, benefits and risks are deemed
satisfactory, a policy recommendation for this vaccine is
possible in 2015. Henceforth, this would pave the way
for decisions within malaria-endemic countries to imple-
ment and scale-up the vaccine through their national
immunization programmes. A Decision-Making Frame-
work has been developed by the World Health Organiza-
tion (WHO) and the PATH Malaria Vaccine Initiative
(MVI) [7] to facilitate timely and informed decisions for
malaria vaccine introduction into health systems in Africa.
Once approved, it is expected that the vaccine will be
distributed within endemic regions of sub-Saharan Africa
for malaria prevention, and be used alongside existing
interventions.
However, the introduction of all new interventions,
and particularly vaccines, requires an understanding of
the local socio-cultural environment. This has been
highlighted by challenges in regions such as northern
Nigeria, where polio vaccination programmes failed to
be accepted by the community due to misconceptions
held and perpetuated by religious leaders [8]. Various
reasons, primarily associated with the vaccination
programme itself, have been found to influence the re-
jection of vaccines by communities in which they have
been introduced. Factors that have contributed to vac-
cine refusal in sub-Saharan Africa include: limited par-
ental and community knowledge of immunization and/or lack of access to information on childhood immu-
nization, insufficient information about target diseases,
negative vaccine attitudes in the community, false per-
ceptions on disease susceptibility and severity, poor
experiences with health care providers, and general con-
cerns about vaccination safety [9,10]. To improve vac-
cine acceptance and childhood immunization coverage
in sub-Saharan Africa, public health programmes should
be designed to address specific barriers faced by diverse
people and communities. Assessing community percep-
tions of malaria vaccine is a key element of the
Decision-Making Framework and would help guide
public discussions and answer critical questions for
strengthened decision-making on the introduction of a
malaria vaccine. Under the leadership of MVI, qualita-
tive studies have been conducted on community expec-
tations and acceptability of the malaria vaccine in
malaria-endemic regions in Kenya, Mozambique and
Ghana [11-13]. In all three countries, there was wide-
spread support for a potential malaria vaccine, provided
it was deemed efficacious and became widely accessible.
It is estimated that about 24 million Kenyans are at risk
of malaria [14]. A study conducted in two malaria en-
demic regions of Kenya, Busia and the South coast, found
that communities supported local childhood immuniza-
tion programmes, although understanding of vaccines and
what they do was limited. These limitations in under-
standing were most pronounced among younger and
older people, particularly men. The current practice to
promote health education on child welfare and immu-
nization is to target women. Findings of the aforemen-
tioned study demonstrate that communications strategies
should be developed to target men and women equally
and in gender-appropriate ways [13]. Furthermore, this
should involve influential community members and pro-
vide needed information and reassurances about immu-
nization. Efforts should also be made to address concerns
about the quality of immunization services and include
improving health workers’ interpersonal communication
skills [15].
The aforementioned studies were focused on exploring
socio cultural and health communication issues among in-
dividuals who are responsible for, or influence decisions
about vaccine use. Furthermore, they were carried out in
resource-limited settings with small, carefully selected
qualitative samples. Additional nationwide quantitative
data are needed with a focus on factors influencing the at-
titudes of child caregivers. Furthermore, an understanding
of community perceptions and acceptability of a malaria
vaccine would be particularly informative in countries
where clinical trials for the vaccine are underway.
This study examined caregivers’ acceptability of a mal-
aria vaccine by using selected determinants to plan for
the introduction of a malaria vaccine.
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Setting
Kenya has four malaria epidemiological zones, with di-
versity in risk determined largely by altitude, rainfall pat-
terns and temperature. The zones are:
 Endemic
Areas of stable malaria have altitudes ranging from 0
to 1,300 m around Lake Victoria in western Kenya
and in the coastal regions. Rainfall, temperature and
humidity are the determinants of the perennial
transmission of malaria. The vector life cycle is
usually short and survival rates are high because of
the suitable climatic conditions. Transmission is
intense throughout the year, with annual
entomological inoculation rates of 30–100 [16].
Western, Nyanza and Coast Provinces fall in these
malaria-endemic zones.
 Seasonal transmission
Arid and semi-arid areas of northern and south-
eastern parts of the country experience short periods
of intense malaria transmission during the rainfall
seasons. Temperatures are usually high and water
pools created during the rainy season provide
breeding sites for the malaria vectors. Extreme
climatic conditions, such as the El Niño southern
oscillation, lead to flooding in these areas, resulting
in epidemic outbreaks with high morbidity rates
owing to the low immune status of the population
[16]. Eastern and North Eastern Provinces and parts
of Central Province fall in this seasonal transmission
zone.
 Epidemic-prone areas of the Western highlands
of Kenya
Malaria transmission in the Western highlands of
Kenya is seasonal, with considerable year-to-year
variation. Epidemics are experienced when climatic
conditions favour sustainability of minimum
temperatures around 18°C. This increase in minimum
temperatures during the long rains favours and
sustains vector breeding, resulting in increased
intensity of malaria transmission. The whole
population is vulnerable and case fatality rates during
an epidemic can be up to ten times greater than those
experienced in regions where malaria occurs regularly
[16]. Rift Valley Province and some parts of Nyanza
Province fall in this zone.
 Low risk malaria areas
This zone covers the central highlands of Kenya,
including Nairobi. The temperatures are usually too
low to allow completion of the development cycle of
the malaria parasite in the mosquito vector.
However, the increasing temperatures and changes
in the hydrological cycle associated with climatechange are likely to increase the areas suitable for
malaria vector breeding with the introduction of
malaria transmission in areas where it had not
existed before [17]. Plasmodium falciparum is the
most prevalent parasite species and counts for 96%
of malaria cases [16]. Nairobi Province and some
parts of Central Province are considered malaria low
risk zones.Study design and sample
Questions on the perceptions of caregivers of sick chil-
dren were included in the 2010 Kenya Service Provision
Assessment Survey (KSPA). The KSPA is a facility-based
survey designed to provide information on the prepared-
ness of health facilities that offer maternal, child, family
planning, and reproductive health services, as well as
services for specific infectious diseases. The components
assessed are those commonly promoted in various pro-
grammes supported by the Government and develop-
ment partners. The child health component of the
survey was designed to assess the acceptability and per-
ceptions of child caregivers about the new malaria vaccine,
among other questions that provided countrywide infor-
mation on child health during the time of the KSPA.
The sample of facilities included in the survey was se-
lected from a Master Facility List (MFL) of 6,192 func-
tioning health facilities in Kenya at the time of the survey.
The list, obtained from the Division of Health Information
Systems, Department of Standards and Regulatory Ser-
vices, included hospitals, health centres, maternity and
nursing homes, clinics, and stand-alone VCT facilities, run
by the different managing authorities, including the
Government of Kenya (GoK), non-governmental organi-
zations (NGOs), private for-profit organizations, and
faith-based organizations (FBOs). A sampling frame was
used to randomly select a representative sample size of
703 health facilities from different levels, from the then
eight provinces in Kenya. The sample was carefully de-
signed to allow for key indicators to be presented at na-
tional and provincial levels, by type of facility, and by the
different managing authorities. The sample covered ap-
proximately 11% of all facilities in the country, and in-
cluded all three national referral hospitals and the eight
provincial hospitals of Kenya. Data were weighted during
the analysis to compensate for over- or under sampling of
various types of facilities, in order to normalize the find-
ings and present data from these facilities, as they exist in
the country.
In the selected health facilities, caregivers of sick chil-
dren were asked to participate in an Exit Interview as
they left the facility. The Exit Interview included ques-
tions on the caregiver’s understanding and perception of
the service delivery, and ascertained the caregiver’s atti-
tude and perception about the new malaria vaccine.
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A standard questionnaire was used for the interview. In-
terviewers sat in on consultations for 2,016 sick children
and observed interactions between caregivers of the sick
children and providers to assess whether the process
followed in service delivery meets standards for accept-
able content and quality. Only children younger than
five years of age who presented with an illness (rather
than an injury or a skin or eye infection exclusively)
were selected for observation. Before leaving the facility,
caregivers of observed sick children were interviewed
about the perceived quality of the provider’s service,
socio-demographic characteristics, and their attitude
toward and perception of a new malaria vaccine. Demo-
graphic data for children whose caregivers were inter-
viewed was also recorded, including the results of
malaria tests done by either microscopy of a blood
smear or by use of a rapid test kit. They were given the
following information about the vaccine prior to answer-
ing the questionnaire:
 The vaccine would reduce the chances of getting
severe malaria (e.g., malaria with convulsions) in a
vaccinated child;
 The vaccine causes discomfort similar to other
childhood vaccines;
 The vaccine may be given at the same health facility
and at the same time as other childhood vaccines.
The vaccine may require four to five jabs (shots) to
receive full benefit;
 Because malaria can occur several times in a child,
and because of how this vaccine is, it may not offer
full protection against all episodes, that is, a child who
is vaccinated with this vaccine could still get malaria;
 The vaccine does not change the need to prevent
malaria through other ways. Even if the child is
vaccinated, his/her family will need to continue
malaria prevention practices (e.g., sleeping under an
insecticide-treated bed net, taking prevention tablets
during pregnancy, having the houses sprayed with
insecticide, etc.)
The caregivers were then asked if they would support
vaccination of a young child in the community with the
future malaria vaccine. Those who had a child or chil-
dren below five years were asked if they would have their
own child vaccinated, and those with no children below
five years were asked whether they would support the
vaccination if they had a child below five years. All re-
spondents were asked to give open-ended reasons why
they would accept or not accept the malaria vaccine.
After completing data collection in each facility,
there were different levels of quality assurance of data. In-
terviewers reviewed the questionnaires before handingthem over to the team leader, who reviewed them a sec-
ond time. A database developed using CSPro software was
used for data entry. All questionnaires were entered twice
to ensure accuracy. STATA v.11 was used for data analysis.
Multinomial regression was applied to analyse the deter-
minants of accepting a child to be immunized with the
malaria vaccine.
Ethical considerations
Informed consent was obtained from facility manage-
ment, and from all interviewed participants. This study
is a continuation of the qualitative study on community
perceptions of a malaria vaccine that was approved by
the African Medical Research Foundation (AMREF) Eth-
ics and Scientific Review Committee. ICF Macro ad-
dressed all ethical issues and released anonymized data set
from the Kenya Service Provision Assessment (KSPA).
Results
Socio demographic characteristics of caregivers
During consultations with sick children, a total of 2,003
caregivers completed the exit interviews between January
and May 2010. Of the caregivers interviewed, 93.5% were
female and 6.5% were male (Table 1). Most of the care-
givers (77%) were in the prime reproductive age group of
20-34 years. Majority of the caregivers interviewed were
related to the child; mothers made up over 90% of the
caregivers, while fathers represented 6% and grandparents
approximately 2%. Most caregivers interviewed were from
the Western Province (17.4%) and the fewest were from
Nairobi Province (7.0%). Most respondents (97%) took
their children to health facilities at the district and lower
levels, which primarily included dispensaries, followed by
district hospitals and health centres. Overall, 72% of the
caregivers were interviewed in government health facilities
or those operated by local authorities (Table 1).
Characteristics of children
Of the 2,016 sick children whose caregivers were inter-
viewed, 53% were male and 47% were female (Table 2).
One third of the children were infants less than
12 months old and approximately another third was be-
tween one and two years old.
Out of 1,973 children with fever, 752 (38.1%) were
clinically diagnosed with malaria. However, of the 1,970
that underwent malaria testing using either microscopic
blood smear examination or a rapid test kit, 317 (16%)
of children tested positive (Table 2). The proportion of
children who tested positive for malaria, in each prov-
ince was as follows: 60% of cases in the Western Prov-
ince, 48% in Nyanza, 42% in Eastern Province, 39% in
the Coast region, 34% in the Rift Valley, and 33% in the
North Eastern Province. The proportion in Nairobi and
Central provinces were 13.5% and 13.7%, respectively.
Table 1 Sociodemographic characteristics of caregivers
interviewed and their distribution by region and facility
type
Characteristics of respondents Frequency (n) Per cent
Sex (n = 1,997)
Female 1,868 93.5
Male 129 6.5














North Eastern 196 9.79
Nyanza 291 14.53
Rift Valley 258 12.88
Western 348 17.37
Facility type attended (n = 2,003)
National referral hospital 10 0.5
Provincial hospital 50 2.5
District hospital 365 18.2
Sub district hospital 309 15.4
Other hospital 286 14.3
























Table 3 Responses by caregivers to questions on the
malaria vaccine
Support for young
child in community to
be vaccinated with the
malaria vaccine
Support own child
to be vaccinated with
the malaria vaccine
Number (n) Per cent Number (n) Per cent
Yes 1,699 88.7 1,645 88.0
No 88 4.6 86 4.6
Don’t know 128 6.7 139 7.4
Total 1,915 100 1,870 100
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Overall, about 88% of caregivers answered that they
would support the vaccine for both a young child in
their community and for their own child, while approxi-
mately 7% of respondents did not know whether they
would support the vaccine and 5% would not support it
(Table 3). Analysis of the distribution by province reveals
that approval is highest in Nyanza (98.9%), Coast (98.7%),
Eastern (97.8%), Central (96.7%), Western (95.4%), Rift
Valley (91%) and Nairobi (87%). North Eastern Province
had the lowest approval with 23% of caregivers stating that
they would support child immunization with the possible
malaria vaccine. Results were comparable for responses tovaccinating a child within the community and one’s own
child (Table 3).
Caregivers were asked to explain why they would
accept or not accept a child to be immunized with the
possible malaria vaccine. Over 92% of caregivers cited
reduced mortality and morbidity as a reason they would
accept their child, as well as a child in the community to
be vaccinated. Furthermore, about 49% of caregivers
who stated that they would not accept the vaccine cited
the combination of possible side effects and incomplete
protection provided by vaccines as reasons.
Educational factors and acceptance of the vaccine
About 86% of caregivers interviewed had attended
school in the past. Out of these, 94% would accept a
child to be vaccinated in their community, while 3%
would not and 3% did not know. Similar results were ob-
served when caregivers were asked if they would accept
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those who had never attended school supported the vac-
cine in the community, and 55% for their own child.
Of the caregivers who had attended school, 60% indi-
cated that the highest level of education they completed
was primary school. Out of these participants, 95%
stated their support for the possible vaccine at the com-
munity level, and 94% supported its use for their own
child. About 39% of caregivers had completed secondary
school education or higher, and of this group, 92% ap-
proved of the vaccine in the community and a similar
proportion approved for their own child.
No literacy was reported by 32% of caregivers. For
those without literacy, only 70% would accept the mal-
aria vaccine for the community and 69% for their own
child. About 64% of caregivers were able to read and
write. Out of these, 96% would accept a child in their
community to be vaccinated with the malaria vaccine
and 95% would accept their own child to be vaccinated.
Four per cent of caregivers indicated that they could
read but could not write, and 73.5 and 71.4% of these re-
ported they would accept the malaria vaccine for the
community and for their own child, respectively.
Acceptance of the vaccine and factors related to
the health facility attended
Proximity to the health facility
About 78% of the caregivers who answered the question
about vaccination of children in the community attendedTable 4 Caregivers’ educational factors and response to accep
Factors Vaccination in community
Yes No Don’t know
% (n)
Ever attended school
Yes (n = 1,603, 85.9%) 94 (1,508) 3.4 (55) 2.6 (41)
No (n = 263, 14.1%) 55.9 (147) 12.6 (33) 31.6 (83)
Total (n = 1,866, 100%) 88.6 (1,655) 4.7 (88) 6.6 (124)
Highest level of education
Primary (n = 959, 59.9%) 95.3 (915) 1.9 (18) 2.8 (27)
Secondary + (n = 641, 40.06%) 92 (590) 5.8 (37) 2.2 (14)
Total (n = 1,600, 100%) 94 (1,505) 2.6 (55) 2.6 (41)
Literacy
Read and write (n = 769, 64%) 96 (738) 1.8 (14) 2.2 (17)
Read only (n = 49, 4.08%) 73.5 (36) 6.1 (3) 20.4 (10)
None (n = 384, 32%) 69.9 (268) 8.6 (33) 21.6 (83)
Total (n = 1,202, 100%) 86.7 (1,042) 4.2 (50) 9.2 (110)
Paid fees for visit
Yes (n = 953, 51%) 91.2 (869) 4.7 (45) 4.1 (39)
No (n = 915, 49%) 86 (788) 4.7 (43) 9.3 (85)
Total (n = 1,868, 100%) 88.7 (1,657) 88 6.6 (124)the health facility closest to their home. Among these,
87% would accept the malaria vaccine for the commu-
nity and 91% for own child. Of those who did not attend
the nearest facility, 94% accepted vaccine for the com-
munity and 85% for own child (Table 5). Out of those
who did not go to the nearest health facility, 21% did so
because the facility had a bad reputation or was more
expensive, while 15% did so due to a lack of required
medicines.Recommendation of the health facility
Ninety-two per cent of caregivers would recommend the
health facility that they attended to a friend. Out of
these, 91% would accept malaria vaccination in their
community and a similar percentage would accept vac-
cination of their own child. In comparison, only 78 and
75% of those who would not recommend the health fa-
cility would support the vaccine for community and own
child, respectively (Table 5).Fee paid for service
About 51% of the caregivers paid fees for services re-
ceived during their visit to the health facility. Of these,
91% would accept a child to be vaccinated with the
malaria vaccine in their community or for their own
children, compared to 86 and 85% acceptance for com-
munity or own child respectively, amongst those who
did not pay fees for the services.tance of the malaria vaccine
Vaccination of own child
Total Yes No Don’t know Total
% (n)
100 (1,604) 93.3 (1,496) 4.2 (67) 2.5 (40) 100 (1,603)
100 (263) 55.1 (145) 7.2 (19) 37.6 (99) 100 (263)
100 (1,867) 87.9 (1,641) 4.6 (86) 7.5 (139) 100 (1,866)
100 (960) 94.3 (904) 2.7 (26) 3.0 (29) 100 (959)
100 (641) 91.9 (589) 6.4 (41) 1.7 (11) 100 (641)
100 (1,601) 93.3 (1,493) 4.2 (67) 2.5 (40) 100 (1,600)
100 (769) 95.1 (731) 2.6 (20) 2.3 (18) 100 (769)
100 (49) 71.4 (35) 8.2 (4) 20.4 (10) 100 (49)
100 (384) 69.1 (265) 5 (19) 26 (100) 100 (384)
100 (1,202) 85.8 (1,031) 3.6 (43) 10.7 (128) 100 (1,202)
100 (953) 90.8 (865) 4.9 (47) 4.3 (41) 100 (953)
100 (916) 85 (778) 4.3 (39) 10.7 (98) 100 (915)
100 (1,869) 88 (1,643) 4.6 (86) 7.4 (139) 100 (1,868)
Table 5 Satisfaction of caregivers with the attended health facility and their response to acceptance of the malaria
vaccine
Factors Vaccination in community Vaccination of own child
Yes No Don’t know Total % (n) Yes No Don’t know Total
Facility nearest home
Yes (n = 953, 51%) 87.2 (1,265) 4.9 (71) 7.9 (114) 100 (1,450) 90.8 (865) 4.9 (47) 41 (4.3) 100 (953)
No (n = 915, 49%) 93.5 (391) 4.1 (17) 2.4 (10) 100 (418) 85 (778) 4.3 (39) 10.7 (98) 100 (915)
Total (n = 1,868, 100%) 88.7 (1,656) 4.7 (88) 6.6 (124) 100 (1,868) 88 (1,643) 4.6 (86) 7.4 (139) 100 (1,868)
Would recommend facility
Yes (n = 1,694, 91.9%) 90.9 (1,540) 4.1 (69) 5.1 (86) 100 (1,695) 90.3 (1,529) 4.3 (72) 5.5 (93) 100 (1,694)
No (n = 108, 5.9%) 77.8 (84) 7.4 (8) 14.8 (16) 100 (108) 75 (81) 9.3 (10) 15.7 (17) 100 (108)
Don't know (n = 41, 2.22%) 31.7 (13) 26.8 (11) 41.5 (17) 100 (41) 31.7 (13) 9.8 (4) 58.5 (24) 100 (41)
Total (n = 1,843, 100) 88.7 (1,637) 4.8 (88) 6.5 (119) 100 (1,844) 88.1 (1,623) 4.7 (86) 7.3 (134) 100 (1,843)
Total 1,651 88 121 1,860 1,637 86 136 1,859
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A multivariate analysis to determine factors associated
with a caregiver accepting a future malaria vaccine dem-
onstrated that region of residence had a large influence
on whether caregivers would accept a future malaria
vaccine or not (Table 6). Residence in Central, Coast,
Eastern, Nyanza, Rift Valley, and Western Provinces sig-
nificantly increased the chances of a caregiver accepting
a child to be vaccinated with the malaria vaccine in one’s
community, as well as own child. On the other hand, a
significantly reduced likelihood of accepting the vaccine
for a child was found for residents of North Eastern
Province.
Caregivers above age 35, particularly those above age
50, and those who never attended school were also sig-
nificantly less likely to accept the vaccine for their own
child. Being somewhat satisfied with the services at the
health facility was associated with a significantly reduced
likelihood of accepting the vaccine for both a child in
one’s community and for their own child, compared to
caregivers who reported being satisfied with health ser-
vices (Table 6). Age of child, proximity of attended
health facility, caregiver relationship to child and other
socio-demographic factors were not associated with ac-
ceptance of a future malaria vaccine.
Discussion
National decisions on the use of a new intervention re-
quire strong supportive data to best facilitate its timely
and systematic uptake. It is critical to gain an under-
standing of the socio-cultural environment prior to
introduction of a possible malaria vaccine, as in the past
it has taken up to two decades for some vaccines to be
available to communities in developing countries [7,18,19].
Upon investigating the acceptability and attitudes of child
caregivers toward a malaria vaccine in all eight regions of
Kenya, it was found that the majority of caregivers wouldsupport the introduction of a malaria vaccine. Previous
studies in Kenya, Tanzania, Mozambique, and Ghana
similarly demonstrated a widespread support for a pos-
sible new malaria vaccine [11-13]. Reduced mortality and
morbidity were the main reasons stated for acceptance of
the vaccine, whereas many would not accept the vaccine
due to a combination of possible side effects and incom-
plete vaccine protection. This is congruent with previous
findings that the more severe and visible the disease, and
the more safe and effective the vaccine is perceived to be,
the greater the acceptance and uptake of the new vaccine
[7,19]. A study of vaccination of children with seasonal in-
fluenza vaccination in Kenya also demonstrated that par-
ents being too busy or their child being away during the
vaccination period were reasons for having declined the
vaccine [19].
Socio-demographic factors underlying acceptance of the
vaccine
The majority (77%) of the caregivers were in their early
and mid-reproductive years (between 20 and 34 years of
age). The results of this study showed that beyond
35 years of age, the chance of a caregiver accepting their
child to be vaccinated with the possible malaria vaccine
decreased progressively with age (RRR 0.3 for age group
35-49 years, compared to 0.1 for age 50 years and
above). This finding is in agreement with other studies,
which have shown that children of caregivers aged above
40 years were more likely to be lag behind in the vaccin-
ation schedule [10,20-22].
Over 90% of the caregivers were mothers, confirming
the prominent role mothers play in taking care of sick
children. This is in line with the observation of the
WHO that women are the main conduits for health
knowledge, the main providers of health care [23]. Even
when both parents are working, the responsibility of care
for sick children usually falls on the mother [23,24]. This
Table 6 Regression of factors related to caregivers accepting vaccination of their own child
Relative risk ratio (RRR) of accepting own child to be
vaccinated with possible malaria vaccine/Not accepting
RRR of not knowing (DK) whether to accept or
not/Not accepting
Factor RRR (95% CI) RRR (95% CI)
Region
NairobiR 1.0 1.0
Central 4.0** (1.7, 11.7) 3.7** (1.5, 9.3)
Coast 13.1*** (3.5, 48.9) 11.6*** (3.2, 42.5)
Eastern 8.7*** (3.0, 25.3) 5.7*** (2.2, 14.7)
North Eastern 0.3* (0.1, 0.8) 0.4 (0.1, 1.1)
Nyanza 12.0*** (3.3, 43.3) 9.0*** (2.9, 28.3)
Rift Valley 3.2** (1.4, 7.7) 2.4* (1.1, 5.2)
Western 3.7** (1.6, 8.3) 2.7* (1.3, 5.6)
Age (years)
<1 1.0
1 - 2 1.3 (0.7, 2.4) 1.1 (0.6, 1.9)
2 - 3 1.4 (0.7, 2.9) 1.2 (0.6, 2.4)
3 - 4 1.1 (0.5, 2.4) 1.0 (0.5, 2.1)
4 - 5 1.2 (0.4, 3.1) 0.8 (0.3, 1.9)
>5 0.5 (0.0, 5.2) 0.5 (0.0, 4.7)
Paid fees
YesR 1.0 1.0
No 1.3 (0.8, 2.2) 1.3 (0.8, 2.0)
Nearest H/F
YesR 1.0 1.0
No 1.1 (0.6, 2.0) 0.8 (0.5, 1.4)
Opinion on services
SatisfiedR 1.0 1.0
Somewhat satisfied 0.5** (0.3, 0.8) 0.5** (0.3, 0.9)
Not satisfied 0.6 (0.2, 1.9) 0.5 (0.2, 1.2)
Relationship to child
MotherR 1.0 1.0
Father 2.0 (0.7, 5.8) 1.4 (0.5, 3.6)
Other 3.3 (0.8, 13.2) 2.6 (0.5, 12.9)
Age of caregiver
<20R 1.0 1.0
20-34 0.8 (0.3, 2.0) 1.1 (0.5, 2.7)
35-49 0.3* (0.1, 0.9) 0.5 (0.2, 1.4)
50+ 0.1* (0.0, 0.7) 0.4 (0.1, 3.0)
Ever attended school
YesR 1.0 1.0
No 0.4* (0.2, 0.9) 0.6 (0.3, 1.4)
Note: ***: p < 0.001; **: p < 0.01; *: p < 0.05.
Omitted categories (R in superscript) are as follows: Region: Nairobi; Age of child: 0-11 months; Paid fees: Yes; Nearest health facility: Yes; Opinion on services:
Satisfied; Relationship to child: Mother; Age of caregiver: <20; Attended school: Yes.
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timely healthcare decisions and enable them to execute
these.Regional context for uptake of a possible malaria vaccine
Findings from this study show that regional disparities,
caregiver opinion on the service, age of the caregiver,
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caregivers accept immunization of children in Kenya.
For example, being a resident of North Eastern Province
is significantly associated with a reduced risk (0.3) of
accepting vaccination. These findings are consistent with
those of the Kenya Demographic and Health Survey
(KDHS), which show that only 48% of children aged be-
tween 12 and 23 months in North Eastern Province re-
ceived all basic vaccinations [14].
The low likelihood of accepting the vaccine in this
Province may be a result of many factors underlying
poor vaccination support and coverage in the socio-
economically disadvantaged North Eastern Province,
including poverty, lack of knowledge, poor health aware-
ness, poor access to healthcare, lack of infrastructure
and religious considerations [25,26]. North Eastern Prov-
ince, located in the drought prone arid lands of northern
Kenya is one of the poorest regions in the country where
majority live below the poverty line, has some of the
worst health indicators in the country, vaccination
coverage is low and school enrolment is low [14,27].
A WHO report [10] identified various immunization
system, family characteristics and parental attitude and
knowledge related barriers to vaccine uptake in Kenya.
Immunization system related reasons/factors linked to
un-vaccinated or under-vaccinated children included:
cost of access to immunizations, inconvenient clinic
schedules, increased distance from vaccination clinic,
other parental duties, missed opportunities due to vac-
cines or supplies stock outs, lost vaccination card, or
child was sick or under weight. Older mothers; low level
of education of mother; divorced mothers; children in
large families and parents with large families were family
factors associated with low vaccine uptake. On the other
hand, the parental attitude and knowledge related factors
associated with low vaccine uptake included very low (or
very high) knowledge level regarding immunizations;
negligence and/or ignorance among caregivers regarding
children's vaccinations; caregivers too ‘busy’ to take chil-
dren to get vaccinations; parental beliefs; lack of motiv-
ation of parents and lack of knowledge of disease. Many
of the factors identified here obtain in North Eastern
Province and may contribute to the low levels of accept-
ance of a malaria vaccine. For instance, about 80% of
girls in the province are not enrolled in school [27] and
only 21% of women in the province are literate, com-
pared to 65% of the men and the overall national average
of 87% [14]. This low literacy levels among women, who
are the primary caregivers of children, may play an im-
portant role in the low acceptance of a malaria vaccine
in North Eastern Province.
In Karachi, Pakistan, Sheik et al. identified the most
common reasons for non-vaccination as a lack of know-
ledge, as well as non-compliant spouse, security conditions,religious taboos, lack of trust in medical facilities, fear of
side effects, accessibility problems, financial problems, and
vaccinations being considered as ineffective [28]. Karachi
and North Eastern Province in Kenya share religious simi-
larities, as well as comparable regional challenges. There is
a dire need for concerted efforts by the central and county
governments to address the socio-economic disparities in
the province, in order to improve acceptability and equit-
able access to health services, including vaccines.
The study found that being a resident of Coast,
Nyanza, Western, Central and Eastern Provinces is sig-
nificantly associated with a higher likelihood of accept-
ing a child to be immunized. As expected, the highest
number of malaria-positive tests was also found in the
malaria-endemic regions of Western, Nyanza and Coast
Provinces, including the seasonal malaria transmission
Eastern Province. High approval rates in these regions
are likely related to residents’ desire to support interven-
tions, which promise to reduce the malaria burden in
their community. Yet, most caregivers in both malaria-
endemic and non-endemic areas would approve vac-
cination of children with a malaria vaccine with the
exception of the North Eastern Province. In the case of
the low-risk malaria regions of Central and Nairobi
Provinces, this may be explained by greater health
awareness and higher literacy levels in these regions.
The fact that people often move into and out of malaria-
endemic zones may also provide a reason why wide-
spread approval of a possible vaccine cuts across the
entire country.
However, the low levels of acceptance witnessed in
North Eastern Province may be due to the general low
uptake of vaccines in the province, related to the factors
mentioned above. On the other hand, it may be linked
to the fact that the area lies in the seasonal malaria
transmission zone where the periods of malaria trans-
mission during the rainfall seasons are short. The prov-
ince generally has low population densities and has
traditionally not been targeted for scaling of malaria pre-
ventive interventions; exhibit highly focal transmission
close to water features [29]. Because of the presumed
low malaria risk, few empirical studies of malaria have
been undertaken in these areas and the malaria situation
among these poor, pastoralist communities remains ill-
defined. The Kenya Malaria Indicator Survey of 2010
[30] found that the level of knowledge of malaria disease,
perception of severity of fever, health seeking behaviour
for fever, perceived affordability and availability of first
line anti-malarials, and perceived efficacy of anti-
malarials in treating fever were related to malaria
endemicity. Women of reproductive age from the semi-
arid seasonal malaria transmission zone that includes
North Eastern Province were less likely to know the first
line treatment for malaria; were likely to perceive fever
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prompt anti-malarial treatment; fewer agreed that fever
treatment was available, and that malaria medicines were
affordable and effective, compared with mothers in
higher risk malaria endemicity zones. In addition, dis-
tance to services has been identified as a reason for low
vaccine uptake by caregivers living in rural and/or re-
mote communities, often in locations without a health
facility [10]. The low knowledge of malaria disease and
low perception of malaria risk by caregivers, coupled
with poor access to health facilities in North Eastern
Province may be linked to the low acceptance of a mal-
aria vaccine. A lot needs to be done to improve health
awareness and access to health services in the North
Eastern Province.
Influence of education on caregiver perceptions
Regression results showed that not having attended
school significantly reduced the likelihood of a caregiver
accepting their child to be immunized with a malaria
vaccine than those who were not schooled. Similarly, a
higher rate of acceptance was found among respondents
who could read and write, compared to those without
literacy. This finding is consistent with previous studies
that showed that children whose caregivers were edu-
cated were more likely to complete their immunization
schedule on time [10,31]. This could be attributed to
various factors, including greater health awareness with
better utilization of health facilities, greater involvement
in decision making regarding child health, ability to
accept new ideas, and greater confidence when dealing
with health professionals [32]. A recent study from
Australia also found that parental confidence in vaccine
safety was significantly associated with a higher level of
education [33].
A randomized controlled trial in Karachi, Pakistan
demonstrated that home-based education for mothers
on the importance of vaccines significantly improved in-
fant immunization rates in low-income and low-literacy
populations [34]. Another trial concluded that provision
of an improved immunization card, centre-based mater-
nal education, or both interventions together improved
childhood immunization adherence [35]. Such immuniza-
tion promotion programmes should be considered in the
North Eastern Province and other low-literacy areas.
Impact of satisfaction with health care services on child
immunization
Being somewhat satisfied with the services offered in a
health facility was significantly related to a reduced like-
lihood (RRR 0.3, p < 0.01) of accepting one’s own child
to be vaccinated with a future malaria vaccine. This find-
ing is in tandem with results from a qualitative study
that was conducted in Coast and Busia regions, whereaccess to vaccination services and attitudes of service pro-
viders were mentioned as barriers to immunization [13].Limitations
This was not a household survey and the caregivers
present on the day of the survey at the selected facilities
might not be representative of the caregivers in the com-
munity who normally seek immunization services. Fur-
thermore, being a hospital-based survey, perceptions of
caregivers on vaccines could be influenced by their ex-
perience in using health services, the quality of their
interaction with health providers, as well as the services
received. Additionally, caregivers were asked why they
would decline or accept a malaria vaccine, yet the re-
sponses were too general, e.g., “reduces mortality”. In fu-
ture studies, this question should be open-ended to
allow for more thorough and informative responses.
During the data collection, the country was stratified
along provincial administrative units but not according
to malaria endemicity zoning. The study cannot there-
fore conclusively relate acceptance of a malaria vaccine
to malaria endemicity zones. Future studies should ex-
plore the correlation between acceptance of a malaria
vaccine and malaria endemicity zones.
It should be noted that this study assessed caregiver
perceptions of a malaria vaccine assuming that it would
be sufficiently efficacious to “reduce the chances of get-
ting severe malaria in a vaccinated child”. Other studies
have highlighted widespread preference of a malaria vac-
cine over drugs, provided that the vaccine is efficacious.
At the time this study was conducted, efficacy results
from clinical trials were limited and in the meantime,
relatively lower efficacy has been found for RTS,S com-
pared to other childhood vaccines [5]. It will therefore
be valuable to assess caregiver perceptions of the vaccine
with final efficacy results and information from the trials
as they conclude. Despite these limitations, this study
demonstrates that introduction of a vaccine for malaria
has overwhelming support from caregivers of sick chil-
dren who visited health facilities.Conclusion
The results of the study show high endorsement and ex-
pectations of malaria vaccination in all regions of the
country. The exception is North Eastern Province, where
the possibility of accepting one’s own child to be vacci-
nated with this future vaccine is low. The overwhelming
support calls for the need to carefully manage the expec-
tations of end users as the vaccine is released in the fu-
ture. The results also point to the need to target specific
segments of child caregivers with relevant messages.
Some of these segments include residents of regions
where acceptance is low, service providers in health
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